Latest Breaking News On - Idiopathic systemic capillary leak syndrome - Page 1 : comparemela.com

/PRNewswire/ PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics,.

South-korea
Daejeon
Taejon-gwangyoksi
Australia
Kirk-druey
Jin-san-yoo
Pharmabcine-inc
Ir-pr-team
Business-development-team
Linkedin
Youtube
Idiopathic-systemic-capillary-leak-syndrome